nodes	percent_of_prediction	percent_of_DWPC	metapath
Clomipramine—Somnambulism—Varenicline—nicotine dependence	0.027	0.0355	CcSEcCtD
Clomipramine—Panic reaction—Varenicline—nicotine dependence	0.027	0.0355	CcSEcCtD
Clomipramine—Night blindness—Varenicline—nicotine dependence	0.023	0.0303	CcSEcCtD
Clomipramine—Sensory disturbance—Varenicline—nicotine dependence	0.0175	0.023	CcSEcCtD
Clomipramine—Peripheral ischaemia—Varenicline—nicotine dependence	0.0148	0.0196	CcSEcCtD
Clomipramine—Haematochezia—Varenicline—nicotine dependence	0.0134	0.0177	CcSEcCtD
Clomipramine—Withdrawal symptom—Varenicline—nicotine dependence	0.0132	0.0174	CcSEcCtD
Clomipramine—Myositis—Varenicline—nicotine dependence	0.011	0.0145	CcSEcCtD
Clomipramine—Drug withdrawal syndrome—Varenicline—nicotine dependence	0.011	0.0145	CcSEcCtD
Clomipramine—Extrapyramidal symptoms—Varenicline—nicotine dependence	0.0104	0.0138	CcSEcCtD
Clomipramine—Suicide—Varenicline—nicotine dependence	0.0104	0.0138	CcSEcCtD
Clomipramine—Hostility—Varenicline—nicotine dependence	0.00978	0.0129	CcSEcCtD
Clomipramine—Sleep disturbance—Varenicline—nicotine dependence	0.00966	0.0127	CcSEcCtD
Clomipramine—Suicide attempt—Varenicline—nicotine dependence	0.00954	0.0126	CcSEcCtD
Clomipramine—Gastric ulcer—Varenicline—nicotine dependence	0.00932	0.0123	CcSEcCtD
Clomipramine—Completed suicide—Varenicline—nicotine dependence	0.00921	0.0121	CcSEcCtD
Clomipramine—Vaginal discharge—Varenicline—nicotine dependence	0.0089	0.0117	CcSEcCtD
Clomipramine—Psoriasis—Varenicline—nicotine dependence	0.00861	0.0113	CcSEcCtD
Clomipramine—Parosmia—Varenicline—nicotine dependence	0.00835	0.011	CcSEcCtD
Clomipramine—Electrocardiogram abnormal—Varenicline—nicotine dependence	0.00826	0.0109	CcSEcCtD
Clomipramine—Paranoia—Varenicline—nicotine dependence	0.00794	0.0105	CcSEcCtD
Clomipramine—Menstrual disorder—Varenicline—nicotine dependence	0.00794	0.0105	CcSEcCtD
Clomipramine—Intestinal obstruction—Varenicline—nicotine dependence	0.00794	0.0105	CcSEcCtD
Clomipramine—Suicidal ideation—Varenicline—nicotine dependence	0.00772	0.0102	CcSEcCtD
Clomipramine—Delusion—Varenicline—nicotine dependence	0.00765	0.0101	CcSEcCtD
Clomipramine—Nystagmus—Varenicline—nicotine dependence	0.00758	0.00999	CcSEcCtD
Clomipramine—Mania—Varenicline—nicotine dependence	0.00744	0.00981	CcSEcCtD
Clomipramine—Extrapyramidal disorder—Varenicline—nicotine dependence	0.00719	0.00947	CcSEcCtD
Clomipramine—Scotoma—Varenicline—nicotine dependence	0.00713	0.00939	CcSEcCtD
Clomipramine—CYP2C19—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00702	0.0415	CbGpPWpGaD
Clomipramine—Gingivitis—Varenicline—nicotine dependence	0.0069	0.00909	CcSEcCtD
Clomipramine—Mydriasis—Varenicline—nicotine dependence	0.00679	0.00894	CcSEcCtD
Clomipramine—Nephrolithiasis—Varenicline—nicotine dependence	0.00674	0.00887	CcSEcCtD
Clomipramine—Glycosuria—Varenicline—nicotine dependence	0.00668	0.00881	CcSEcCtD
Clomipramine—Dysphonia—Varenicline—nicotine dependence	0.00658	0.00867	CcSEcCtD
Clomipramine—Endocrine disorder—Varenicline—nicotine dependence	0.00653	0.00861	CcSEcCtD
Clomipramine—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00646	0.0381	CbGpPWpGaD
Clomipramine—Acne—Varenicline—nicotine dependence	0.00643	0.00848	CcSEcCtD
Clomipramine—Disturbance in attention—Varenicline—nicotine dependence	0.00625	0.00823	CcSEcCtD
Clomipramine—Aggression—Varenicline—nicotine dependence	0.00616	0.00812	CcSEcCtD
Clomipramine—Gastrooesophageal reflux disease—Varenicline—nicotine dependence	0.00599	0.0079	CcSEcCtD
Clomipramine—Thinking abnormal—Varenicline—nicotine dependence	0.00591	0.00779	CcSEcCtD
Clomipramine—Nocturia—Varenicline—nicotine dependence	0.00584	0.00769	CcSEcCtD
Clomipramine—HRH2—cardiovascular system—nicotine dependence	0.00554	0.118	CbGeAlD
Clomipramine—Coordination abnormal—Varenicline—nicotine dependence	0.00551	0.00726	CcSEcCtD
Clomipramine—Blood pressure increased—Varenicline—nicotine dependence	0.00541	0.00713	CcSEcCtD
Clomipramine—Eructation—Varenicline—nicotine dependence	0.00532	0.00701	CcSEcCtD
Clomipramine—Salivary hypersecretion—Varenicline—nicotine dependence	0.00526	0.00693	CcSEcCtD
Clomipramine—Nightmare—Varenicline—nicotine dependence	0.00523	0.00689	CcSEcCtD
Clomipramine—Photophobia—Varenicline—nicotine dependence	0.00508	0.0067	CcSEcCtD
Clomipramine—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.00504	0.0298	CbGpPWpGaD
Clomipramine—Oesophagitis—Varenicline—nicotine dependence	0.00495	0.00652	CcSEcCtD
Clomipramine—Urine output increased—Varenicline—nicotine dependence	0.00489	0.00645	CcSEcCtD
Clomipramine—Mouth ulceration—Varenicline—nicotine dependence	0.00489	0.00645	CcSEcCtD
Clomipramine—Hypertonia—Varenicline—nicotine dependence	0.00475	0.00625	CcSEcCtD
Clomipramine—Mental disability—Varenicline—nicotine dependence	0.0047	0.00619	CcSEcCtD
Clomipramine—Euphoric mood—Varenicline—nicotine dependence	0.00465	0.00613	CcSEcCtD
Clomipramine—Lymphadenopathy—Varenicline—nicotine dependence	0.00461	0.00607	CcSEcCtD
Clomipramine—Sleep disorder—Varenicline—nicotine dependence	0.00454	0.00598	CcSEcCtD
Clomipramine—Diabetes mellitus—Varenicline—nicotine dependence	0.00452	0.00595	CcSEcCtD
Clomipramine—Polyuria—Varenicline—nicotine dependence	0.00448	0.0059	CcSEcCtD
Clomipramine—Deafness—Varenicline—nicotine dependence	0.00439	0.00579	CcSEcCtD
Clomipramine—Disorientation—Varenicline—nicotine dependence	0.00439	0.00579	CcSEcCtD
Clomipramine—Eczema—Varenicline—nicotine dependence	0.00437	0.00576	CcSEcCtD
Clomipramine—HRH2—Monoamine GPCRs—DRD2—nicotine dependence	0.00436	0.0258	CbGpPWpGaD
Clomipramine—CYP2C19—Xenobiotics—CYP2A7—nicotine dependence	0.00435	0.0257	CbGpPWpGaD
Clomipramine—Eye pain—Varenicline—nicotine dependence	0.00435	0.00574	CcSEcCtD
Clomipramine—Hot flush—Varenicline—nicotine dependence	0.0042	0.00554	CcSEcCtD
Clomipramine—Increased appetite—Varenicline—nicotine dependence	0.00418	0.00551	CcSEcCtD
Clomipramine—Menopausal symptoms—Varenicline—nicotine dependence	0.00416	0.00549	CcSEcCtD
Clomipramine—Thirst—Varenicline—nicotine dependence	0.00413	0.00544	CcSEcCtD
Clomipramine—Cerebrovascular accident—Varenicline—nicotine dependence	0.00401	0.00528	CcSEcCtD
Clomipramine—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.004	0.0236	CbGpPWpGaD
Clomipramine—GSTP1—cardiovascular system—nicotine dependence	0.00399	0.0849	CbGeAlD
Clomipramine—Gastrointestinal haemorrhage—Varenicline—nicotine dependence	0.00393	0.00518	CcSEcCtD
Clomipramine—Osteoarthritis—Varenicline—nicotine dependence	0.00393	0.00518	CcSEcCtD
Clomipramine—Affect lability—Varenicline—nicotine dependence	0.00387	0.0051	CcSEcCtD
Clomipramine—Migraine—Varenicline—nicotine dependence	0.00387	0.0051	CcSEcCtD
Clomipramine—Psychotic disorder—Varenicline—nicotine dependence	0.00384	0.00506	CcSEcCtD
Clomipramine—Irritability—Varenicline—nicotine dependence	0.00375	0.00494	CcSEcCtD
Clomipramine—Urinary retention—Varenicline—nicotine dependence	0.00374	0.00492	CcSEcCtD
Clomipramine—Mood swings—Varenicline—nicotine dependence	0.00372	0.00491	CcSEcCtD
Clomipramine—HRH2—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00367	0.0217	CbGpPWpGaD
Clomipramine—Dry skin—Varenicline—nicotine dependence	0.0036	0.00475	CcSEcCtD
Clomipramine—Hypokalaemia—Varenicline—nicotine dependence	0.00358	0.00471	CcSEcCtD
Clomipramine—Breast disorder—Varenicline—nicotine dependence	0.00355	0.00468	CcSEcCtD
Clomipramine—GSTP1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.0035	0.0207	CbGpPWpGaD
Clomipramine—Gastritis—Varenicline—nicotine dependence	0.00348	0.00458	CcSEcCtD
Clomipramine—Dysphagia—Varenicline—nicotine dependence	0.0034	0.00448	CcSEcCtD
Clomipramine—CYP1A2—Xenobiotics—CYP2A7—nicotine dependence	0.00339	0.02	CbGpPWpGaD
Clomipramine—HTR6—Monoamine GPCRs—DRD2—nicotine dependence	0.00335	0.0198	CbGpPWpGaD
Clomipramine—GSTP1—Biological oxidations—CYP2A7—nicotine dependence	0.0033	0.0195	CbGpPWpGaD
Clomipramine—HTR2B—cardiovascular system—nicotine dependence	0.00329	0.07	CbGeAlD
Clomipramine—Bronchitis—Varenicline—nicotine dependence	0.00327	0.0043	CcSEcCtD
Clomipramine—GSTP1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00325	0.0192	CbGpPWpGaD
Clomipramine—Pollakiuria—Varenicline—nicotine dependence	0.00314	0.00413	CcSEcCtD
Clomipramine—Erectile dysfunction—Varenicline—nicotine dependence	0.00313	0.00412	CcSEcCtD
Clomipramine—GSTP1—midbrain—nicotine dependence	0.00312	0.0663	CbGeAlD
Clomipramine—Photosensitivity reaction—Varenicline—nicotine dependence	0.0031	0.00409	CcSEcCtD
Clomipramine—Weight increased—Varenicline—nicotine dependence	0.00309	0.00407	CcSEcCtD
Clomipramine—Hyperglycaemia—Varenicline—nicotine dependence	0.00306	0.00404	CcSEcCtD
Clomipramine—HTR2B—Monoamine GPCRs—DRD2—nicotine dependence	0.00306	0.018	CbGpPWpGaD
Clomipramine—Depression—Varenicline—nicotine dependence	0.00302	0.00398	CcSEcCtD
Clomipramine—Acute coronary syndrome—Varenicline—nicotine dependence	0.00299	0.00393	CcSEcCtD
Clomipramine—HTR6—brain—nicotine dependence	0.00297	0.0633	CbGeAlD
Clomipramine—Myocardial infarction—Varenicline—nicotine dependence	0.00297	0.00391	CcSEcCtD
Clomipramine—Conjunctivitis—Varenicline—nicotine dependence	0.00294	0.00388	CcSEcCtD
Clomipramine—Hepatobiliary disease—Varenicline—nicotine dependence	0.00286	0.00377	CcSEcCtD
Clomipramine—Epistaxis—Varenicline—nicotine dependence	0.00286	0.00376	CcSEcCtD
Clomipramine—Sinusitis—Varenicline—nicotine dependence	0.00284	0.00374	CcSEcCtD
Clomipramine—HTR6—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00281	0.0166	CbGpPWpGaD
Clomipramine—Bradycardia—Varenicline—nicotine dependence	0.00277	0.00365	CcSEcCtD
Clomipramine—HTR2C—midbrain—nicotine dependence	0.00273	0.0582	CbGeAlD
Clomipramine—HRH2—brain—nicotine dependence	0.00272	0.0578	CbGeAlD
Clomipramine—Hypoaesthesia—Varenicline—nicotine dependence	0.00271	0.00356	CcSEcCtD
Clomipramine—Hallucination—Varenicline—nicotine dependence	0.00271	0.00356	CcSEcCtD
Clomipramine—Urinary tract disorder—Varenicline—nicotine dependence	0.00268	0.00354	CcSEcCtD
Clomipramine—Connective tissue disorder—Varenicline—nicotine dependence	0.00267	0.00352	CcSEcCtD
Clomipramine—Urethral disorder—Varenicline—nicotine dependence	0.00267	0.00351	CcSEcCtD
Clomipramine—Visual impairment—Varenicline—nicotine dependence	0.00262	0.00345	CcSEcCtD
Clomipramine—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.00262	0.0155	CbGpPWpGaD
Clomipramine—Adinazolam—GABRA4—nicotine dependence	0.00261	0.106	CrCbGaD
Clomipramine—SLC6A4—midbrain—nicotine dependence	0.00259	0.0552	CbGeAlD
Clomipramine—HTR2B—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00257	0.0152	CbGpPWpGaD
Clomipramine—Eye disorder—Varenicline—nicotine dependence	0.00254	0.00335	CcSEcCtD
Clomipramine—Tinnitus—Varenicline—nicotine dependence	0.00253	0.00334	CcSEcCtD
Clomipramine—Cardiac disorder—Varenicline—nicotine dependence	0.00252	0.00332	CcSEcCtD
Clomipramine—Angiopathy—Varenicline—nicotine dependence	0.00247	0.00325	CcSEcCtD
Clomipramine—HTR2C—Monoamine GPCRs—DRD2—nicotine dependence	0.00246	0.0145	CbGpPWpGaD
Clomipramine—Immune system disorder—Varenicline—nicotine dependence	0.00246	0.00324	CcSEcCtD
Clomipramine—Mediastinal disorder—Varenicline—nicotine dependence	0.00245	0.00323	CcSEcCtD
Clomipramine—Chills—Varenicline—nicotine dependence	0.00244	0.00321	CcSEcCtD
Clomipramine—Arrhythmia—Varenicline—nicotine dependence	0.00243	0.0032	CcSEcCtD
Clomipramine—Mental disorder—Varenicline—nicotine dependence	0.00238	0.00314	CcSEcCtD
Clomipramine—Malnutrition—Varenicline—nicotine dependence	0.00237	0.00312	CcSEcCtD
Clomipramine—Flurazepam—GABRA4—nicotine dependence	0.00236	0.0956	CrCbGaD
Clomipramine—Flatulence—Varenicline—nicotine dependence	0.00233	0.00307	CcSEcCtD
Clomipramine—Dysgeusia—Varenicline—nicotine dependence	0.00232	0.00305	CcSEcCtD
Clomipramine—Back pain—Varenicline—nicotine dependence	0.00229	0.00302	CcSEcCtD
Clomipramine—Muscle spasms—Varenicline—nicotine dependence	0.00228	0.003	CcSEcCtD
Clomipramine—Vision blurred—Varenicline—nicotine dependence	0.00223	0.00294	CcSEcCtD
Clomipramine—Tremor—Varenicline—nicotine dependence	0.00222	0.00292	CcSEcCtD
Clomipramine—Ill-defined disorder—Varenicline—nicotine dependence	0.0022	0.00289	CcSEcCtD
Clomipramine—Anaemia—Varenicline—nicotine dependence	0.00219	0.00288	CcSEcCtD
Clomipramine—Agitation—Varenicline—nicotine dependence	0.00217	0.00287	CcSEcCtD
Clomipramine—HTR2A—Monoamine GPCRs—DRD2—nicotine dependence	0.00214	0.0126	CbGpPWpGaD
Clomipramine—Malaise—Varenicline—nicotine dependence	0.00213	0.00281	CcSEcCtD
Clomipramine—Vertigo—Varenicline—nicotine dependence	0.00213	0.0028	CcSEcCtD
Clomipramine—Syncope—Varenicline—nicotine dependence	0.00212	0.0028	CcSEcCtD
Clomipramine—Palpitations—Varenicline—nicotine dependence	0.00209	0.00276	CcSEcCtD
Clomipramine—SLC6A4—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00208	0.0123	CbGpPWpGaD
Clomipramine—Loss of consciousness—Varenicline—nicotine dependence	0.00208	0.00274	CcSEcCtD
Clomipramine—HTR2C—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00207	0.0122	CbGpPWpGaD
Clomipramine—Cough—Varenicline—nicotine dependence	0.00207	0.00272	CcSEcCtD
Clomipramine—Convulsion—Varenicline—nicotine dependence	0.00205	0.0027	CcSEcCtD
Clomipramine—Hypertension—Varenicline—nicotine dependence	0.00204	0.00269	CcSEcCtD
Clomipramine—Chest pain—Varenicline—nicotine dependence	0.00201	0.00265	CcSEcCtD
Clomipramine—Arthralgia—Varenicline—nicotine dependence	0.00201	0.00265	CcSEcCtD
Clomipramine—Myalgia—Varenicline—nicotine dependence	0.00201	0.00265	CcSEcCtD
Clomipramine—Anxiety—Varenicline—nicotine dependence	0.00201	0.00265	CcSEcCtD
Clomipramine—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.002	0.00264	CcSEcCtD
Clomipramine—Discomfort—Varenicline—nicotine dependence	0.00199	0.00262	CcSEcCtD
Clomipramine—Dry mouth—Varenicline—nicotine dependence	0.00197	0.0026	CcSEcCtD
Clomipramine—GSTP1—brain—nicotine dependence	0.00196	0.0417	CbGeAlD
Clomipramine—ADRA2A—Monoamine GPCRs—DRD2—nicotine dependence	0.00195	0.0115	CbGpPWpGaD
Clomipramine—Oedema—Varenicline—nicotine dependence	0.00193	0.00255	CcSEcCtD
Clomipramine—Shock—Varenicline—nicotine dependence	0.0019	0.0025	CcSEcCtD
Clomipramine—Nervous system disorder—Varenicline—nicotine dependence	0.00189	0.0025	CcSEcCtD
Clomipramine—Thrombocytopenia—Varenicline—nicotine dependence	0.00189	0.00249	CcSEcCtD
Clomipramine—Tachycardia—Varenicline—nicotine dependence	0.00189	0.00248	CcSEcCtD
Clomipramine—Skin disorder—Varenicline—nicotine dependence	0.00188	0.00247	CcSEcCtD
Clomipramine—Hyperhidrosis—Varenicline—nicotine dependence	0.00187	0.00246	CcSEcCtD
Clomipramine—Anorexia—Varenicline—nicotine dependence	0.00184	0.00243	CcSEcCtD
Clomipramine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00181	0.0107	CbGpPWpGaD
Clomipramine—Hypotension—Varenicline—nicotine dependence	0.0018	0.00238	CcSEcCtD
Clomipramine—HRH2—GPCR ligand binding—TAS2R16—nicotine dependence	0.0018	0.0106	CbGpPWpGaD
Clomipramine—HTR2A—Amine ligand-binding receptors—DRD2—nicotine dependence	0.0018	0.0106	CbGpPWpGaD
Clomipramine—CYP2C19—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00178	0.0105	CbGpPWpGaD
Clomipramine—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00176	0.00232	CcSEcCtD
Clomipramine—HTR2A—cardiovascular system—nicotine dependence	0.00176	0.0374	CbGeAlD
Clomipramine—Insomnia—Varenicline—nicotine dependence	0.00175	0.0023	CcSEcCtD
Clomipramine—Dyspnoea—Varenicline—nicotine dependence	0.00172	0.00227	CcSEcCtD
Clomipramine—HTR2C—brain—nicotine dependence	0.00172	0.0366	CbGeAlD
Clomipramine—Somnolence—Varenicline—nicotine dependence	0.00172	0.00226	CcSEcCtD
Clomipramine—Dyspepsia—Varenicline—nicotine dependence	0.0017	0.00224	CcSEcCtD
Clomipramine—Decreased appetite—Varenicline—nicotine dependence	0.00168	0.00221	CcSEcCtD
Clomipramine—ALB—brain—nicotine dependence	0.00168	0.0357	CbGeAlD
Clomipramine—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00167	0.0022	CcSEcCtD
Clomipramine—Fatigue—Varenicline—nicotine dependence	0.00167	0.00219	CcSEcCtD
Clomipramine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00166	0.00982	CbGpPWpGaD
Clomipramine—Pain—Varenicline—nicotine dependence	0.00165	0.00218	CcSEcCtD
Clomipramine—Constipation—Varenicline—nicotine dependence	0.00165	0.00218	CcSEcCtD
Clomipramine—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00164	0.00969	CbGpPWpGaD
Clomipramine—ADRA2A—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00164	0.00966	CbGpPWpGaD
Clomipramine—SLC6A4—brain—nicotine dependence	0.00163	0.0347	CbGeAlD
Clomipramine—HTR2B—brain—nicotine dependence	0.00161	0.0343	CbGeAlD
Clomipramine—ADRA2A—midbrain—nicotine dependence	0.00161	0.0343	CbGeAlD
Clomipramine—Feeling abnormal—Varenicline—nicotine dependence	0.00159	0.0021	CcSEcCtD
Clomipramine—Gastrointestinal pain—Varenicline—nicotine dependence	0.00158	0.00208	CcSEcCtD
Clomipramine—Urticaria—Varenicline—nicotine dependence	0.00153	0.00202	CcSEcCtD
Clomipramine—Body temperature increased—Varenicline—nicotine dependence	0.00153	0.00201	CcSEcCtD
Clomipramine—Abdominal pain—Varenicline—nicotine dependence	0.00153	0.00201	CcSEcCtD
Clomipramine—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00147	0.00865	CbGpPWpGaD
Clomipramine—SLC6A2—brain—nicotine dependence	0.00143	0.0305	CbGeAlD
Clomipramine—Hypersensitivity—Varenicline—nicotine dependence	0.00142	0.00188	CcSEcCtD
Clomipramine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00141	0.00832	CbGpPWpGaD
Clomipramine—CYP1A2—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00139	0.00821	CbGpPWpGaD
Clomipramine—SLC6A4—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00139	0.00819	CbGpPWpGaD
Clomipramine—Asthenia—Varenicline—nicotine dependence	0.00139	0.00183	CcSEcCtD
Clomipramine—HTR6—GPCR ligand binding—TAS2R16—nicotine dependence	0.00138	0.00816	CbGpPWpGaD
Clomipramine—HTR2A—midbrain—nicotine dependence	0.00137	0.0292	CbGeAlD
Clomipramine—Pruritus—Varenicline—nicotine dependence	0.00137	0.0018	CcSEcCtD
Clomipramine—Triflupromazine—DRD2—nicotine dependence	0.00136	0.055	CrCbGaD
Clomipramine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00135	0.00796	CbGpPWpGaD
Clomipramine—ADRA2A—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00133	0.00784	CbGpPWpGaD
Clomipramine—Diarrhoea—Varenicline—nicotine dependence	0.00132	0.00174	CcSEcCtD
Clomipramine—Dizziness—Varenicline—nicotine dependence	0.00128	0.00168	CcSEcCtD
Clomipramine—HTR2B—GPCR ligand binding—TAS2R16—nicotine dependence	0.00126	0.00745	CbGpPWpGaD
Clomipramine—SLC6A4—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00126	0.00744	CbGpPWpGaD
Clomipramine—Acepromazine—DRD2—nicotine dependence	0.00125	0.0509	CrCbGaD
Clomipramine—HTR2A—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00125	0.00739	CbGpPWpGaD
Clomipramine—Vomiting—Varenicline—nicotine dependence	0.00123	0.00162	CcSEcCtD
Clomipramine—Thioproperazine—DRD2—nicotine dependence	0.00123	0.0497	CrCbGaD
Clomipramine—Rash—Varenicline—nicotine dependence	0.00122	0.0016	CcSEcCtD
Clomipramine—Dermatitis—Varenicline—nicotine dependence	0.00122	0.0016	CcSEcCtD
Clomipramine—Headache—Varenicline—nicotine dependence	0.00121	0.00159	CcSEcCtD
Clomipramine—Pipotiazine—DRD2—nicotine dependence	0.00121	0.0489	CrCbGaD
Clomipramine—Amitriptyline—OPRM1—nicotine dependence	0.00118	0.0478	CrCbGaD
Clomipramine—HRH2—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00116	0.00688	CbGpPWpGaD
Clomipramine—Prochlorperazine—DRD2—nicotine dependence	0.00115	0.0467	CrCbGaD
Clomipramine—ABCB1—cardiovascular system—nicotine dependence	0.00115	0.0245	CbGeAlD
Clomipramine—Nausea—Varenicline—nicotine dependence	0.00115	0.00151	CcSEcCtD
Clomipramine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00114	0.00674	CbGpPWpGaD
Clomipramine—SLC6A4—Circadian rythm related genes—CHRNB2—nicotine dependence	0.00113	0.00669	CbGpPWpGaD
Clomipramine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00109	0.00642	CbGpPWpGaD
Clomipramine—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00107	0.00633	CbGpPWpGaD
Clomipramine—HRH2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00102	0.00601	CbGpPWpGaD
Clomipramine—HTR2C—GPCR ligand binding—TAS2R16—nicotine dependence	0.00102	0.00601	CbGpPWpGaD
Clomipramine—ADRA2A—brain—nicotine dependence	0.00101	0.0216	CbGeAlD
Clomipramine—Propiomazine—DRD2—nicotine dependence	0.001	0.0407	CrCbGaD
Clomipramine—HRH2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000998	0.00589	CbGpPWpGaD
Clomipramine—Chlorprothixene—DRD2—nicotine dependence	0.000949	0.0385	CrCbGaD
Clomipramine—Nortriptyline—DRD2—nicotine dependence	0.000931	0.0378	CrCbGaD
Clomipramine—HRH2—Signaling by GPCR—TAS2R16—nicotine dependence	0.000925	0.00546	CbGpPWpGaD
Clomipramine—ABCB1—midbrain—nicotine dependence	0.000899	0.0191	CbGeAlD
Clomipramine—Thioridazine—DRD2—nicotine dependence	0.000898	0.0364	CrCbGaD
Clomipramine—HTR6—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000893	0.00527	CbGpPWpGaD
Clomipramine—HTR2A—GPCR ligand binding—TAS2R16—nicotine dependence	0.000884	0.00522	CbGpPWpGaD
Clomipramine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000881	0.0052	CbGpPWpGaD
Clomipramine—Trimipramine—DRD2—nicotine dependence	0.000877	0.0356	CrCbGaD
Clomipramine—HTR2A—brain—nicotine dependence	0.000862	0.0183	CbGeAlD
Clomipramine—Methotrimeprazine—DRD2—nicotine dependence	0.000857	0.0348	CrCbGaD
Clomipramine—Promethazine—DRD2—nicotine dependence	0.000844	0.0342	CrCbGaD
Clomipramine—HRH2—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000842	0.00497	CbGpPWpGaD
Clomipramine—SLC6A4—Circadian rythm related genes—DRD2—nicotine dependence	0.000838	0.00495	CbGpPWpGaD
Clomipramine—Doxepin—DRD2—nicotine dependence	0.000836	0.0339	CrCbGaD
Clomipramine—HTR2A—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.000835	0.00493	CbGpPWpGaD
Clomipramine—Trifluoperazine—DRD2—nicotine dependence	0.000833	0.0338	CrCbGaD
Clomipramine—CYP2C19—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000826	0.00488	CbGpPWpGaD
Clomipramine—Perphenazine—DRD2—nicotine dependence	0.000824	0.0334	CrCbGaD
Clomipramine—HTR2B—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000815	0.00481	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR ligand binding—TAS2R16—nicotine dependence	0.000804	0.00475	CbGpPWpGaD
Clomipramine—HRH2—GPCR downstream signaling—FGD1—nicotine dependence	0.000799	0.00472	CbGpPWpGaD
Clomipramine—CYP2D6—brain—nicotine dependence	0.000785	0.0167	CbGeAlD
Clomipramine—HTR6—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000781	0.00461	CbGpPWpGaD
Clomipramine—CYP2C19—Biological oxidations—CYP2A7—nicotine dependence	0.000779	0.0046	CbGpPWpGaD
Clomipramine—CYP2C19—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000768	0.00453	CbGpPWpGaD
Clomipramine—Desipramine—DRD2—nicotine dependence	0.000767	0.0311	CrCbGaD
Clomipramine—HTR6—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000765	0.00452	CbGpPWpGaD
Clomipramine—HRH2—GPCR ligand binding—OPRM1—nicotine dependence	0.00076	0.00449	CbGpPWpGaD
Clomipramine—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00076	0.00448	CbGpPWpGaD
Clomipramine—HTR2A—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.000759	0.00448	CbGpPWpGaD
Clomipramine—Promazine—DRD2—nicotine dependence	0.000743	0.0301	CrCbGaD
Clomipramine—HRH2—Signaling by GPCR—FGD1—nicotine dependence	0.000726	0.00429	CbGpPWpGaD
Clomipramine—HRH2—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000722	0.00426	CbGpPWpGaD
Clomipramine—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.000716	0.00423	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000713	0.00421	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—TAS2R16—nicotine dependence	0.00071	0.00419	CbGpPWpGaD
Clomipramine—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000706	0.00417	CbGpPWpGaD
Clomipramine—HTR2B—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000699	0.00412	CbGpPWpGaD
Clomipramine—HTR2C—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000658	0.00388	CbGpPWpGaD
Clomipramine—Chlorpromazine—DRD2—nicotine dependence	0.000654	0.0265	CrCbGaD
Clomipramine—Imipramine—DRD2—nicotine dependence	0.00065	0.0264	CrCbGaD
Clomipramine—HTR2B—Signaling by GPCR—TAS2R16—nicotine dependence	0.000648	0.00382	CbGpPWpGaD
Clomipramine—Amitriptyline—DRD2—nicotine dependence	0.000646	0.0262	CrCbGaD
Clomipramine—HTR6—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000646	0.00381	CbGpPWpGaD
Clomipramine—CYP1A2—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000644	0.0038	CbGpPWpGaD
Clomipramine—SLC6A2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00063	0.00372	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—FGD1—nicotine dependence	0.000613	0.00362	CbGpPWpGaD
Clomipramine—CYP1A2—Biological oxidations—CYP2A7—nicotine dependence	0.000607	0.00358	CbGpPWpGaD
Clomipramine—CYP1A2—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000598	0.00353	CbGpPWpGaD
Clomipramine—HTR2B—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00059	0.00348	CbGpPWpGaD
Clomipramine—HTR6—GPCR ligand binding—OPRM1—nicotine dependence	0.000583	0.00344	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000575	0.0034	CbGpPWpGaD
Clomipramine—HTR2A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000571	0.00337	CbGpPWpGaD
Clomipramine—ABCB1—brain—nicotine dependence	0.000565	0.012	CbGeAlD
Clomipramine—GSTP1—Metabolism—CYP2A7—nicotine dependence	0.000564	0.00333	CbGpPWpGaD
Clomipramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000564	0.00333	CbGpPWpGaD
Clomipramine—ADRA2A—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00056	0.00331	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—FGD1—nicotine dependence	0.00056	0.0033	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—FGD1—nicotine dependence	0.000557	0.00329	CbGpPWpGaD
Clomipramine—HTR6—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000553	0.00327	CbGpPWpGaD
Clomipramine—HRH2—GPCR ligand binding—DRD2—nicotine dependence	0.000549	0.00324	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—TAS2R16—nicotine dependence	0.000547	0.00323	CbGpPWpGaD
Clomipramine—HTR2B—GPCR ligand binding—OPRM1—nicotine dependence	0.000532	0.00314	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—TAS2R16—nicotine dependence	0.000523	0.00308	CbGpPWpGaD
Clomipramine—ADRA2A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00052	0.00307	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—FGD1—nicotine dependence	0.000508	0.003	CbGpPWpGaD
Clomipramine—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000505	0.00298	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.0005	0.00295	CbGpPWpGaD
Clomipramine—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000497	0.00293	CbGpPWpGaD
Clomipramine—HTR2A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000489	0.00289	CbGpPWpGaD
Clomipramine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000476	0.00281	CbGpPWpGaD
Clomipramine—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000468	0.00276	CbGpPWpGaD
Clomipramine—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000462	0.00273	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000455	0.00268	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000454	0.00268	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—FGD1—nicotine dependence	0.000452	0.00267	CbGpPWpGaD
Clomipramine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000445	0.00263	CbGpPWpGaD
Clomipramine—HRH2—GPCR downstream signaling—OPRM1—nicotine dependence	0.000429	0.00254	CbGpPWpGaD
Clomipramine—HTR2C—GPCR ligand binding—OPRM1—nicotine dependence	0.000429	0.00253	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—FGD1—nicotine dependence	0.000429	0.00253	CbGpPWpGaD
Clomipramine—HTR6—GPCR ligand binding—DRD2—nicotine dependence	0.000421	0.00249	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—TAS2R16—nicotine dependence	0.000419	0.00247	CbGpPWpGaD
Clomipramine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000413	0.00244	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000413	0.00244	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—FGD1—nicotine dependence	0.00041	0.00242	CbGpPWpGaD
Clomipramine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000408	0.00241	CbGpPWpGaD
Clomipramine—ADRA2A—G alpha (i) signalling events—DRD2—nicotine dependence	0.000405	0.00239	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—FGD1—nicotine dependence	0.000392	0.00231	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—OPRM1—nicotine dependence	0.00039	0.0023	CbGpPWpGaD
Clomipramine—HTR2B—GPCR ligand binding—DRD2—nicotine dependence	0.000385	0.00227	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—TAS2R16—nicotine dependence	0.000383	0.00226	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—AKR1B10—nicotine dependence	0.000379	0.00224	CbGpPWpGaD
Clomipramine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000376	0.00222	CbGpPWpGaD
Clomipramine—HTR2A—GPCR ligand binding—OPRM1—nicotine dependence	0.000373	0.0022	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—FGD1—nicotine dependence	0.000357	0.00211	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—FGD1—nicotine dependence	0.000356	0.0021	CbGpPWpGaD
Clomipramine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000354	0.00209	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR ligand binding—OPRM1—nicotine dependence	0.000339	0.002	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—OPRM1—nicotine dependence	0.000329	0.00194	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—FGD1—nicotine dependence	0.000329	0.00194	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—FGD1—nicotine dependence	0.000324	0.00191	CbGpPWpGaD
Clomipramine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000322	0.0019	CbGpPWpGaD
Clomipramine—ALB—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000317	0.00187	CbGpPWpGaD
Clomipramine—HRH2—GPCR downstream signaling—DRD2—nicotine dependence	0.000311	0.00183	CbGpPWpGaD
Clomipramine—HTR2C—GPCR ligand binding—DRD2—nicotine dependence	0.00031	0.00183	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—TAS2R16—nicotine dependence	0.000309	0.00182	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—OPRM1—nicotine dependence	0.000301	0.00177	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—FGD1—nicotine dependence	0.0003	0.00177	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—OPRM1—nicotine dependence	0.000299	0.00177	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—AKR1B10—nicotine dependence	0.000291	0.00172	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—DRD2—nicotine dependence	0.000282	0.00166	CbGpPWpGaD
Clomipramine—ABCB1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000277	0.00164	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—OPRM1—nicotine dependence	0.000273	0.00161	CbGpPWpGaD
Clomipramine—HTR2A—GPCR ligand binding—DRD2—nicotine dependence	0.000269	0.00159	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—TAS2R16—nicotine dependence	0.000268	0.00158	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—WASF2—nicotine dependence	0.000267	0.00158	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—AKR1B10—nicotine dependence	0.000265	0.00157	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—WASF1—nicotine dependence	0.000256	0.00151	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR ligand binding—DRD2—nicotine dependence	0.000245	0.00145	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—TAS2R16—nicotine dependence	0.000244	0.00144	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—OPRM1—nicotine dependence	0.000243	0.00143	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—FGD1—nicotine dependence	0.000242	0.00143	CbGpPWpGaD
Clomipramine—HTR6—GPCR downstream signaling—DRD2—nicotine dependence	0.000238	0.00141	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—OPRM1—nicotine dependence	0.00023	0.00136	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—OPRM1—nicotine dependence	0.00022	0.0013	CbGpPWpGaD
Clomipramine—HTR2B—GPCR downstream signaling—DRD2—nicotine dependence	0.000217	0.00128	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—DRD2—nicotine dependence	0.000216	0.00128	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—AKR1B10—nicotine dependence	0.000214	0.00126	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—OPRM1—nicotine dependence	0.000211	0.00124	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—FGD1—nicotine dependence	0.00021	0.00124	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—WASF2—nicotine dependence	0.000205	0.00121	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—DRD2—nicotine dependence	0.000197	0.00117	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—WASF1—nicotine dependence	0.000196	0.00116	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—OPRM1—nicotine dependence	0.000192	0.00113	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—FGD1—nicotine dependence	0.000191	0.00113	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—OPRM1—nicotine dependence	0.000191	0.00113	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—CYP2A7—nicotine dependence	0.000188	0.00111	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—WASF2—nicotine dependence	0.000187	0.0011	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—AKR1B10—nicotine dependence	0.000186	0.0011	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—WASF1—nicotine dependence	0.000179	0.00106	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—OPRM1—nicotine dependence	0.000177	0.00104	CbGpPWpGaD
Clomipramine—HTR2C—GPCR downstream signaling—DRD2—nicotine dependence	0.000175	0.00104	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—OPRM1—nicotine dependence	0.000174	0.00103	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—AKR1B10—nicotine dependence	0.000169	0.000998	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—DRD2—nicotine dependence	0.000167	0.000983	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—OPRM1—nicotine dependence	0.000161	0.000952	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—DRD2—nicotine dependence	0.000159	0.00094	CbGpPWpGaD
Clomipramine—HTR2A—GPCR downstream signaling—DRD2—nicotine dependence	0.000152	0.000899	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—WASF2—nicotine dependence	0.000151	0.00089	CbGpPWpGaD
Clomipramine—ALB—Metabolism—CYP2A7—nicotine dependence	0.000148	0.000876	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—WASF1—nicotine dependence	0.000145	0.000853	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—DRD2—nicotine dependence	0.000139	0.000818	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—DRD2—nicotine dependence	0.000138	0.000816	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—CYP2A7—nicotine dependence	0.000133	0.000786	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—WASF2—nicotine dependence	0.000131	0.000773	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—OPRM1—nicotine dependence	0.00013	0.000768	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—CYP2A7—nicotine dependence	0.00013	0.000767	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—DRD2—nicotine dependence	0.000128	0.000754	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—DRD2—nicotine dependence	0.000126	0.000743	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—WASF1—nicotine dependence	0.000126	0.000741	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—CYP2A7—nicotine dependence	0.000122	0.000723	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—WASF2—nicotine dependence	0.000119	0.000703	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—DRD2—nicotine dependence	0.000117	0.000688	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—WASF1—nicotine dependence	0.000114	0.000674	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—OPRM1—nicotine dependence	0.000113	0.000667	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—CYP2A7—nicotine dependence	0.000104	0.000612	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—OPRM1—nicotine dependence	0.000103	0.000607	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—DRD2—nicotine dependence	9.41e-05	0.000555	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—DRD2—nicotine dependence	8.17e-05	0.000482	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CYP2A7—nicotine dependence	8.01e-05	0.000473	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—DRD2—nicotine dependence	7.43e-05	0.000439	CbGpPWpGaD
